-
公开(公告)号：US06627739B1
公开(公告)日：2003-09-30
申请号：US09724566
申请日：2000-11-28
申请人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John P. Anderson , Guriqbal Basi , Minh Tam Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： C07K1640
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00
摘要： Disclosed are various forms of an active, isolated &bgr;-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (&bgr;-APPwt and &bgr;-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate &bgr;-secretase. Inhibitors of &bgr;-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20050164294A1
公开(公告)日：2005-07-28
申请号：US11090866
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/68 , C07H21/04
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw-) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 也公开了单独或与其一些天然底物（β-APPwt和β-APPsw-）组合产生该酶的重组细胞，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20050177888A1
公开(公告)日：2005-08-11
申请号：US11090872
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/68 , A01K67/027 , C07H21/04 , G01N33/53 , G01N33/567
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US20050196839A1
公开(公告)日：2005-09-08
申请号：US11090399
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C07H21/04
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US20050170489A1
公开(公告)日：2005-08-04
申请号：US11069377
申请日：2005-02-28
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
摘要翻译： 公开了各种形式的纯化和重组形式的活性，分离的β-分泌酶。 这种酶涉及积聚在患有阿尔茨海默病的个体的脑中的淀粉样蛋白斑块成分的产生。 产生该酶的重组细胞单独或与其一些天然底物（β-APPwt和β-APPsw）组合也被公开，以及针对这种蛋白质的抗体。 这些组合物可用于选择调节β-分泌酶的化合物的方法。 β-分泌酶的抑制剂涉及作为治疗神经变性疾病如阿尔茨海默病的治疗剂。
-
公开(公告)号：US20050164327A1
公开(公告)日：2005-07-28
申请号：US11089918
申请日：2005-03-25
申请人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
发明人： John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
IPC分类号： A61K38/00 , C12N9/64 , H01Q1/36 , H01Q1/38 , H01Q3/44 , H01Q5/00 , H01Q9/04 , H01Q15/02 , C12Q1/37
CPC分类号： C12N9/6478 , A01K2217/075 , A61K38/00 , H01Q1/364 , H01Q1/38 , H01Q3/44 , H01Q9/0407 , H01Q9/0442 , H01Q15/02
摘要： Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
-
公开(公告)号：US07718413B2
公开(公告)日：2010-05-18
申请号：US12341336
申请日：2008-12-22
申请人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
发明人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
CPC分类号： C12N9/6478
摘要： Human BACE polypeptides having modifications to the N-linked glycosylation sites including one or more of the following amino acid substitutions: S174I, N223A, N153Q and N354S. DNA sequences, vectors, and host cells for producing the polypeptides. Crystalline protein compositions formed from the purified polypeptides. Methods of screening for compounds that inhibit Aβ using the polypeptides.
摘要翻译： 具有N连接糖基化位点修饰的人BACE多肽包括一个或多个以下氨基酸取代：S174I，N223A，N153Q和N354S。 DNA序列，载体和用于产生多肽的宿主细胞。 由纯化的多肽形成的结晶蛋白质组合物。 筛选抑制A＆bgr的化合物的方法 使用多肽。
-
公开(公告)号：US20090286281A1
公开(公告)日：2009-11-19
申请号：US12341336
申请日：2008-12-22
申请人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
发明人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
CPC分类号： C12N9/6478
摘要： Human BACE polypeptides having modifications to the N-linked glycosylation sites including one or more of the following amino acid substitutions: S174I, N223A, N153Q and N354S. DNA sequences, vectors, and host cells for producing the polypeptides. Crystalline protein compositions formed from the purified polypeptides. Methods of screening for compounds that inhibit Aβ using the polypeptides.
摘要翻译： 具有N连接糖基化位点修饰的人BACE多肽包括一个或多个以下氨基酸取代：S174I，N223A，N153Q和N354S。 DNA序列，载体和用于产生多肽的宿主细胞。 由纯化的多肽形成的结晶蛋白质组合物。 筛选使用多肽抑制Abeta的化合物的方法。
-
公开(公告)号：US07482136B2
公开(公告)日：2009-01-27
申请号：US10837021
申请日：2004-04-30
申请人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
发明人： John Anderson , Lisa McConlogue , Guriqbal Basi , Sukanto Sinha
CPC分类号： C12N9/6478
摘要： Human BACE polypeptides having modifications to the N-linked glycosylation sites including one or more of the following amino acid substitutions: S174I, N223A, N153Q and N354S. DNA sequences, vectors, and host cells for producing the polypeptides. Crystalline protein compositions formed from the purified polypeptides. Methods of screening for compounds that inhibit Aβ using the polypeptides.
摘要翻译： 具有N连接糖基化位点修饰的人BACE多肽包括一个或多个以下氨基酸取代：S174I，N223A，N153Q和N354S。 DNA序列，载体和用于产生多肽的宿主细胞。 由纯化的多肽形成的结晶蛋白质组合物。 筛选使用多肽抑制Abeta的化合物的方法。
-
公开(公告)号：US5783434A
公开(公告)日：1998-07-21
申请号：US467607
申请日：1995-06-06
申请人： Jay S. Tung , Sukanto Sinha , Lisa McConlogue , Gwen Tatsuno , John Anderson , Susanna Chrysler
发明人： Jay S. Tung , Sukanto Sinha , Lisa McConlogue , Gwen Tatsuno , John Anderson , Susanna Chrysler
IPC分类号： A61K38/00 , C07K5/06 , C07K5/065 , C07K5/072 , C12N9/64 , C12N9/00 , C07H21/02 , C07H21/04 , C12Q1/68
CPC分类号： C07K5/06078 , C07K5/06034 , C07K5/06095 , C12N9/6472 , A61K38/00
摘要： Methods for inhibiting the secretion of .beta.-amyloid peptide (.beta.AP) from cells comprise administering to the cells certain compounds which inhibit the activity of an approximately 31 kD protease involved in .beta.AP secretion. The 31 kD protease has been designated Cathepsin Y. Screening methods for .beta.AP inhibitors rely on determining the activity of test compounds in the presence of Cathepsin Y and a suitable peptide substrate. This invention is also directed to a nucleic acid sequence that encodes Cathepsin Y and the expression and isolation of Cathepsin Y.
-
-
-
-
-
-
-
-
-
搜索结果
25 条记录 (耗时 0.048 秒)
